Global partnerships for the highest quality
Quality and innovation from a single source through our first-class partners!
At ADREXpharma, we believe in the power of strong partnerships. That is why we work with first-class companies that share our vision and embody the highest standards of quality and innovation. The guiding principle “From Seeds to Patient” reflects our commitment to the entire value chain. By working closely and professionally with our partners, we have control over the entire supply chain – from growing the seeds to the finished product.
This guarantees not only the highest quality, but also maximum transparency and traceability.
Medipharm Labs specializes in the development and production of purified pharmaceutical grade cannabis concentrates, active pharmaceutical ingredients and advanced derivatives. Medipharm is considered a pioneer in the field of innovative cannabis medicines.
Pideka operates a “state of the art” indoor facility for the cultivation of pharmaceutical craft cannabis near Bogota. Pideka is one of the few producers in South America to have been issued a European GMP certificate. In this way, Pideka combines the Colombian zest for life with pharmaceutical expertise, all “Hecho a mano”.
Krieger offers specialized, GDP-compliant logistics solutions for narcotics with the highest safety standards and complete traceability. From secure storage with access controls and video surveillance to alarm-protected transportation, we ensure maximum security and compliance. State-of-the-art technology and comprehensive certifications guarantee the reliable and legally compliant handling of BtM products.
Beacon ‘s medicinal cannabis strains are grown in an indoor facility in Canada and are an important part of Canadian cannabis therapy. Thanks to its international acceptance, Beacon has also become an elementary component of cannabis care in Australia with a clear focus on economical patient care.
Breathe Life Sciences – “Redefining medicine”
Breathe Life Sciences (“BLS”) is a wholly owned subsidiary of Australian listed company Bioxyne Ltd (BXN:ASX). BLS holds a license to manufacture medicinal cannabis, psilocybin and MDMA with full GMP certification for active ingredients and finished products.
BLS is the largest producer of medicinal cannabis products in Australia and a pioneer in the production of medicinal pastilles (gummy bears).
BLS processes around 30 tons of cannabis flowers per year, which come from sun, greenhouse and indoor cultivation. BLS has been supplying first-class medicinal cannabis from Australian cultivation to Germany via Adrex Pharma since 2025.
Dr Watson ® “Created by nature, backed by science”. Dr Watson is a globally recognized brand, wholly owned and exclusively manufactured by BLS. Dr Watson products, including lozenges, inhalants, oral and topical cannabis-based solutions, are sold in Australia, the UK, Japan, Germany and other EU markets.
BG LABS is a Colombian pharmaceutical company and member of the German Boettger Group, which specializes in the cultivation and production of medicinal cannabis and is certified by the German authorities according to EU-GMP.
BG LABS guarantees the highest pharmaceutical quality in all processes. The cultivation takes place in the highlands of Boyacá, a region in Colombia known for its optimal altitude, sunshine and rich agricultural tradition. Sustainable cultivation methods are used that respect the natural growth cycle and promote biodiversity. This includes carefully trimming each flower by hand to preserve its full integrity and therapeutic potential.
BG LABS combines pharmaceutical excellence, outstanding quality, environmental protection and social commitment to bring high-quality Colombian cannabis to the German market.
